(BTI) British American Tobacco - Ratings and Ratios
Cigarettes, Heated Tobacco, Vapor Products, Oral Nicotine
BTI EPS (Earnings per Share)
BTI Revenue
Description: BTI British American Tobacco
British American Tobacco p.l.c. (NYSE: BTI) is a global tobacco and nicotine company that sells a full spectrum of products-including combustible cigarettes, vapour devices, heated-tobacco systems, and modern oral nicotine items-across the Americas, Europe, Asia-Pacific, the Middle East, Africa and the United States. Its portfolio spans well-known brands such as Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit and Camel, and distribution is primarily through retail outlets.
Founded in 1902 and headquartered in London, BTI operates under the GICS sub-industry “Tobacco” and trades as a common stock. In FY 2023 the company reported net revenue of $30.9 billion and an adjusted EBITDA margin of ≈ 35 %, reflecting a modest shift toward higher-margin reduced-risk products (RRPs) that now contribute roughly 15 % of total sales volume.
Key economic drivers for BTI include: (1) regulatory pressure-particularly plain-pack mandates and flavor bans-that compresses growth in the combustible segment; (2) commodity cost exposure, especially to tobacco leaf and aluminum, which can erode margins when global prices rise; and (3) currency fluctuations, given that a substantial share of revenue is earned outside the eurozone and the United Kingdom, making the pound and euro exchange rates material to earnings.
From a sector perspective, the tobacco industry’s long-term growth is increasingly tied to the successful rollout of RRPs and the ability to monetize “next-generation” nicotine products in markets where traditional cigarettes are in decline.
For a deeper, data-driven assessment of BTI’s valuation multiples and scenario analysis, you may find the free research tools on ValueRay useful as a next step.
BTI Stock Overview
| Market Cap in USD | 112,753m |
| Sub-Industry | Tobacco |
| IPO / Inception | 1980-04-14 |
BTI Stock Ratings
| Growth Rating | 88.4% |
| Fundamental | 83.1% |
| Dividend Rating | 67.4% |
| Return 12m vs S&P 500 | 35.4% |
| Analyst Rating | 3.40 of 5 |
BTI Dividends
| Dividend Yield 12m | 7.24% |
| Yield on Cost 5y | 16.46% |
| Annual Growth 5y | 2.35% |
| Payout Consistency | 88.8% |
| Payout Ratio | 2.0% |
BTI Growth Ratios
| Growth Correlation 3m | -44.3% |
| Growth Correlation 12m | 96.1% |
| Growth Correlation 5y | 62.2% |
| CAGR 5y | 20.79% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.80 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.96 |
| Sharpe Ratio 12m | 2.80 |
| Alpha | 49.84 |
| Beta | 0.180 |
| Volatility | 18.64% |
| Current Volume | 4041.7k |
| Average Volume 20d | 3930.4k |
| Stop Loss | 50 (-3.1%) |
| Signal | 0.02 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.75b TTM) > 0 and > 6% of Revenue (6% = 3.11b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 6.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.10% (prev -4.31%; Δ 0.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 16.29b > Net Income -10.75b (YES >=105%, WARN >=100%) |
| Net Debt (-4.40b) to EBITDA (20.79b) ratio: -0.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.21b) change vs 12m ago -1.14% (target <= -2.0% for YES) |
| Gross Margin 82.49% (prev 73.90%; Δ 8.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.23% (prev 29.04%; Δ 16.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.64 (EBITDA TTM 20.79b / Interest Expense TTM 3.54b) >= 6 (WARN >= 3) |
Altman Z'' 2.30
| (A) -0.02 = (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b |
| (B) 0.21 = Retained Earnings (Balance) 22.99b / Total Assets 110.23b |
| (C) 0.14 = EBIT TTM 16.41b / Avg Total Assets 114.47b |
| (D) 0.74 = Book Value of Equity 46.75b / Total Liabilities 63.05b |
| Total Rating: 2.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.12
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 16.29% = 5.0 |
| 3. FCF Margin 36.14% = 7.50 |
| 4. Debt/Equity 0.75 = 2.22 |
| 5. Debt/Ebitda -0.21 = 2.50 |
| 6. ROIC - WACC (= 21.59)% = 12.50 |
| 7. RoE -20.99% = -2.50 |
| 8. Rev. Trend 79.93% = 5.99 |
| 9. EPS Trend -12.07% = -0.60 |
What is the price of BTI shares?
Over the past week, the price has changed by +0.16%, over one month by -6.53%, over three months by +2.02% and over the past year by +56.34%.
Is British American Tobacco a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BTI is around 61.34 USD . This means that BTI is currently undervalued and has a potential upside of +18.83% (Margin of Safety).
Is BTI a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 7.5% |
| Analysts Target Price | 55.5 | 7.5% |
| ValueRay Target Price | 66.4 | 28.6% |
Last update: 2025-10-11 02:32
BTI Fundamental Data Overview
P/E Trailing = 27.3191
P/E Forward = 10.7875
P/S = 4.4051
P/B = 1.8117
P/EG = 0.4041
Beta = 0.18
Revenue TTM = 51.78b GBP
EBIT TTM = 16.41b GBP
EBITDA TTM = 20.79b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 114.90b GBP (83.98b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 4.64 (Ebit TTM 16.41b / Interest Expense TTM 3.54b)
FCF Yield = 16.29% (FCF TTM 18.71b / Enterprise Value 114.90b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.04 (Enterprise Value 114.90b / Total Assets 110.23b)
Interest Expense / Debt = 1.99% (Interest Expense 704.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.44b (EBIT 16.41b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.79b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.75% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.76% (EBIT 16.41b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.78% (NOPAT 13.44b / Invested Capital 50.21b)
WACC = 5.19% (E(83.98b)/V(119.30b) * Re(6.68%) + D(35.33b)/V(119.30b) * Rd(1.99%) * (1-Tc(0.18)))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.57%
[DCF Debug] Terminal Value 79.68% ; FCFE base≈16.22b ; Y1≈17.92b ; Y5≈23.23b
Fair Price DCF = 185.2 (DCF Value 403.71b / Shares Outstanding 2.18b; 5y FCF grow 12.09% → 3.0% )
EPS Correlation: -12.07 | EPS CAGR: -31.65% | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.93 | Revenue CAGR: 23.50% | SUE: N/A | # QB: 0
Additional Sources for BTI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle